Bio­gen­er­a­tion Ven­tures rais­es $119M for new fund, adding a per­son­al record to se­ries of VC rais­es

The last few months, for all its eco­nom­ic up­heaval, have been kind to bio­med­ical ven­ture firms.

ARCH raised a bil­lion and a half, Flag­ship an­oth­er bil­lion, and a smat­ter­ing of oth­er funds from ven­Bio to At­las added a few hun­dred mil­lion each to new funds. In com­par­i­son to those Amer­i­can-based heavy­weights, Nether­lands-based Bio­gen­er­a­tion Ven­tures (BGV) has been a con­sid­er­ably small­er play­er.

Yet they, too, just raised their largest fund yet: €105 mil­lion, or $118 mil­lion. The to­tal near­ly dou­bles what the firm had raised in 3 pre­vi­ous rounds.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.